325 related articles for article (PubMed ID: 32213586)
1. Oncogenic human herpesvirus hijacks proline metabolism for tumorigenesis.
Choi UY; Lee JJ; Park A; Zhu W; Lee HR; Choi YJ; Yoo JS; Yu C; Feng P; Gao SJ; Chen S; Eoh H; Jung JU
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8083-8093. PubMed ID: 32213586
[TBL] [Abstract][Full Text] [Related]
2. The Proline Cycle As a Potential Cancer Therapy Target.
Tanner JJ; Fendt SM; Becker DF
Biochemistry; 2018 Jun; 57(25):3433-3444. PubMed ID: 29648801
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC.
Liu W; Le A; Hancock C; Lane AN; Dang CV; Fan TW; Phang JM
Proc Natl Acad Sci U S A; 2012 Jun; 109(23):8983-8. PubMed ID: 22615405
[TBL] [Abstract][Full Text] [Related]
4. PYCR, a key enzyme in proline metabolism, functions in tumorigenesis.
Li Y; Bie J; Song C; Liu M; Luo J
Amino Acids; 2021 Dec; 53(12):1841-1850. PubMed ID: 34273023
[TBL] [Abstract][Full Text] [Related]
5. Isozymes of P5C reductase (PYCR) in human diseases: focus on cancer.
Hu CA
Amino Acids; 2021 Dec; 53(12):1835-1840. PubMed ID: 34291342
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic Kaposi's Sarcoma-Associated Herpesvirus Upregulates Argininosuccinate Synthase 1, a Rate-Limiting Enzyme of the Citrulline-Nitric Oxide Cycle, To Activate the STAT3 Pathway and Promote Growth Transformation.
Li T; Zhu Y; Cheng F; Lu C; Jung JU; Gao SJ
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463977
[TBL] [Abstract][Full Text] [Related]
7. 3D culture conditions support Kaposi's sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells.
Dubich T; Dittrich A; Bousset K; Geffers R; Büsche G; Köster M; Hauser H; Schulz TF; Wirth D
J Mol Med (Berl); 2021 Mar; 99(3):425-438. PubMed ID: 33484281
[TBL] [Abstract][Full Text] [Related]
8. An endothelial cell line infected by Kaposi's sarcoma-associated herpes virus (KSHV) allows the investigation of Kaposi's sarcoma and the validation of novel viral inhibitors in vitro and in vivo.
Dubich T; Lieske A; Santag S; Beauclair G; Rückert J; Herrmann J; Gorges J; Büsche G; Kazmaier U; Hauser H; Stadler M; Schulz TF; Wirth D
J Mol Med (Berl); 2019 Mar; 97(3):311-324. PubMed ID: 30610257
[TBL] [Abstract][Full Text] [Related]
9. Cellular microRNA-127-3p suppresses oncogenic herpesvirus-induced transformation and tumorigenesis via down-regulation of SKP2.
Lee SM; Kaye KM; Slack FJ
Proc Natl Acad Sci U S A; 2021 Nov; 118(45):. PubMed ID: 34725152
[TBL] [Abstract][Full Text] [Related]
10. Structure, biochemistry, and gene expression patterns of the proline biosynthetic enzyme pyrroline-5-carboxylate reductase (PYCR), an emerging cancer therapy target.
Bogner AN; Stiers KM; Tanner JJ
Amino Acids; 2021 Dec; 53(12):1817-1834. PubMed ID: 34003320
[TBL] [Abstract][Full Text] [Related]
11. K1 gene transformation activities in AIDS-related and classic type Kaposi's sarcoma: Correlation with clinical presentation.
Tamanaha-Nakasone A; Uehara K; Tanabe Y; Ishikawa H; Yamakawa N; Toyoda Z; Kurima K; Kina S; Tsuneki M; Okubo Y; Yamaguchi S; Utsumi D; Takahashi K; Arakawa H; Arasaki A; Kinjo T
Sci Rep; 2019 Apr; 9(1):6416. PubMed ID: 31015491
[TBL] [Abstract][Full Text] [Related]
12. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
Katano H
Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
[TBL] [Abstract][Full Text] [Related]
13. K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.
Steinbrück L; Gustems M; Medele S; Schulz TF; Lutter D; Hammerschmidt W
J Virol; 2015 Jul; 89(14):7248-61. PubMed ID: 25948739
[TBL] [Abstract][Full Text] [Related]
14. Structural analysis of the Kaposi's sarcoma-associated herpesvirus K1 protein.
Lee BS; Connole M; Tang Z; Harris NL; Jung JU
J Virol; 2003 Jul; 77(14):8072-86. PubMed ID: 12829846
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic herpesvirus KSHV Hijacks BMP-Smad1-Id signaling to promote tumorigenesis.
Liang D; Hu H; Li S; Dong J; Wang X; Wang Y; He L; He Z; Gao Y; Gao SJ; Lan K
PLoS Pathog; 2014 Jul; 10(7):e1004253. PubMed ID: 25010525
[TBL] [Abstract][Full Text] [Related]
16. Proline: an essential intermediate in arginine degradation in Saccharomyces cerevisiae.
Brandriss MC; Magasanik B
J Bacteriol; 1980 Sep; 143(3):1403-10. PubMed ID: 6997271
[TBL] [Abstract][Full Text] [Related]
17. Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus.
Wang L; Dittmer DP; Tomlinson CC; Fakhari FD; Damania B
Cancer Res; 2006 Apr; 66(7):3658-66. PubMed ID: 16585191
[TBL] [Abstract][Full Text] [Related]
18. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
[TBL] [Abstract][Full Text] [Related]
19. SIRT1-mediated downregulation of p27Kip1 is essential for overcoming contact inhibition of Kaposi's sarcoma-associated herpesvirus transformed cells.
He M; Yuan H; Tan B; Bai R; Kim HS; Bae S; Che L; Kim JS; Gao SJ
Oncotarget; 2016 Nov; 7(46):75698-75711. PubMed ID: 27708228
[TBL] [Abstract][Full Text] [Related]
20. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]